Literature DB >> 26368941

Refractory bipolar disorder and neuroprogression.

Sabrina C da Costa1, Ives C Passos2, Caroline Lowri1, Jair C Soares1, Flavio Kapczinski3.   

Abstract

Immune activation and failure of physiologic compensatory mechanisms over time have been implicated in the pathophysiology of illness progression in bipolar disorder. Recent evidence suggests that such changes are important contributors to neuroprogression and may mediate the cross-sensitization of episode recurrence, trauma exposure and substance use. The present review aims to discuss the potential factors related to bipolar disorder refractoriness and neuroprogression. In addition, we will discuss the possible impacts of early therapeutic interventions as well as the alternative approaches in late stages of the disorder.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bipolar disorder; Neuroprogression; Sensitization/cross-sensitization; Therapeutic interventions; Treatment refractoriness

Mesh:

Year:  2015        PMID: 26368941     DOI: 10.1016/j.pnpbp.2015.09.005

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  8 in total

1.  Individualized identification of euthymic bipolar disorder using the Cambridge Neuropsychological Test Automated Battery (CANTAB) and machine learning.

Authors:  Mon-Ju Wu; Ives Cavalcante Passos; Isabelle E Bauer; Luca Lavagnino; Bo Cao; Giovana B Zunta-Soares; Flávio Kapczinski; Benson Mwangi; Jair C Soares
Journal:  J Affect Disord       Date:  2015-12-30       Impact factor: 4.839

2.  The CINP Guidelines on the Definition and Evidence-Based Interventions for Treatment-Resistant Bipolar Disorder.

Authors:  Konstantinos N Fountoulakis; Lakshmi N Yatham; Heinz Grunze; Eduard Vieta; Allan H Young; Pierre Blier; Mauricio Tohen; Siegfried Kasper; Hans Jurgen Moeller
Journal:  Int J Neuropsychopharmacol       Date:  2020-04-23       Impact factor: 5.176

3.  Behavioral, affective, and cognitive alterations induced by individual and combined environmental stressors in rats.

Authors:  Francisco Diego Rabelo-da-Ponte; Jessica Maria Pessoa Gomes; Nathércia Lima Torres; João Ilo Coelho Barbosa; Geanne Matos de Andrade; Danielle Macedo; Bruno Ceppi
Journal:  Braz J Psychiatry       Date:  2019-03-14       Impact factor: 2.697

Review 4.  Translational evidence for lithium-induced brain plasticity and neuroprotection in the treatment of neuropsychiatric disorders.

Authors:  Stefano Puglisi-Allegra; Stefano Ruggieri; Francesco Fornai
Journal:  Transl Psychiatry       Date:  2021-07-05       Impact factor: 6.222

Review 5.  Consensus on nomenclature for clinical staging models in bipolar disorder: A narrative review from the International Society for Bipolar Disorders (ISBD) Staging Task Force.

Authors:  Ralph Kupka; Anne Duffy; Jan Scott; Jorge Almeida; Vicent Balanzá-Martínez; Boris Birmaher; David J Bond; Elisa Brietzke; Ines Chendo; Benicio N Frey; Iria Grande; Danella Hafeman; Tomas Hajek; Manon Hillegers; Marcia Kauer-Sant'Anna; Rodrigo B Mansur; Afra van der Markt; Robert Post; Mauricio Tohen; Hailey Tremain; Gustavo Vazquez; Eduard Vieta; Lakshmi N Yatham; Michael Berk; Martin Alda; Flávio Kapczinski
Journal:  Bipolar Disord       Date:  2021-07-23       Impact factor: 5.345

6.  The Staging of Major Mood Disorders: Clinical and Neurobiological Correlates.

Authors:  Ather Muneer; Rana Mazommil
Journal:  Psychiatry Investig       Date:  2018-08-20       Impact factor: 2.505

7.  A clinical staging model for bipolar disorder: longitudinal approach.

Authors:  Lorena de la Fuente-Tomás; Pilar Sierra; Mónica Sanchez-Autet; Belén Arranz; Ana García-Blanco; Gemma Safont; Maria P García-Portilla
Journal:  Transl Psychiatry       Date:  2020-01-29       Impact factor: 6.222

Review 8.  Lithium as a Neuroprotective Agent for Bipolar Disorder: An Overview.

Authors:  Enrique L M Ochoa
Journal:  Cell Mol Neurobiol       Date:  2021-08-06       Impact factor: 5.046

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.